Страна: Австралия
Язык: английский
Источник: Department of Health (Therapeutic Goods Administration)
heparin sodium, Quantity: 5000 IU/mL
Pfizer Australia Pty Ltd
Injection, solution
Excipient Ingredients: water for injections; hydrochloric acid; sodium hydroxide
Intravenous, Subcutaneous
5mL x 50
Medicine Registered
(S4) Prescription Only Medicine
INDICATIONS AS AT 26 NOVEMBER 2001: Prophylaxis and treatment of thromboembolic disorders such as thrombophlebitis, pulmonary embolism, coronary or venous thrombosis and occlusive vascular disease. As a low-dose regimen for the prevention of thromboembolic complications arising as a result of cardiac and arterial surgery. As an anticoagulant during blood transfusions, extracorporeal circulation, dialysis and other perfusion techniques and in blood samples for laboratory purposes.
Visual Identification: Clear, colourless or straw coloured solution, free from visible impurities.; Container Type: Ampoule; Container Material: LDPE; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius
Registered
1994-06-22
HEPARIN INJECTION _Heparin sodium_ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Heparin Injection. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have benefits and risks. Your doctor has weighed the risks of you using Heparin Injection against the benefits they expect it will have for you. This medicine is likely to be used while you are at the clinic or in hospital. If possible, please read this leaflet carefully before this medicine is given to you. In some cases, this leaflet may be given to you after the medicine has been used. IF YOU HAVE ANY CONCERNS ABOUT USING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET. You may need to read it again. WHAT HEPARIN INJECTION IS USED FOR Heparin Injection belongs to a group of medicines known as anticoagulants. Anticoagulants work by decreasing the clotting ability of your blood and help stop clots forming in the blood vessels. Anticoagulants are sometimes called "blood thinners", although they do not actually thin the blood. Heparin will not dissolve blood clots that have already formed, but it may prevent any clots that have already formed from becoming larger and causing serious problems. Heparin Injection is used for prevention and treatment of diseases caused by blood clots such as in certain blood vessel, heart and lung conditions. It is also used to prevent blood clots from forming during surgery, dialysis or blood transfusions. Heparin Injection may be used for the treatment of other conditions that are not mentioned above. Your doctor will be able to tell you about the specific condition for which you have been prescribed Heparin Injection. This medicine is available only with a doctor's prescription. This medicine is not addictive. BEFORE YOU ARE GIVEN HEPARIN INJECTION _WHEN YOU MUST NOT BE GIVEN_ _IT_ DO NOT USE HEPARIN INJECTION IF YOU: • have an allergy to heparin or pork products • have, or may Прочитать полный документ
Version: pfphepai10321 Supersedes: pfphepai10819 Page 1 of 14 AUSTRALIAN PRODUCT INFORMATION – HEPARIN INJECTION (HEPARIN SODIUM (PORCINE MUCOUS)) 1. NAME OF THE MEDICINE Heparin sodium 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Heparin Injection contains Heparin sodium 5,000 IU/5 mL or 25,000 IU/5 mL For the full list of excipients, see Section 6.1 List of excipients. Heparin sodium is a preparation containing the sodium salt of a sulphated glucosaminoglycan present in mammalian tissues. It is prepared from the lungs or from the intestinal mucosae of pigs. Heparin sodium is a white or almost white powder, moderately hygroscopic, freely soluble in water. 3. PHARMACEUTICAL FORM Solution for injection. Heparin Injection is a clear, colourless to straw coloured, sterile, preservative-free solution. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS • prophylaxis and treatment of thromboembolic disorders such as thrombophlebitis, pulmonary embolism, coronary or venous thrombosis and occlusive vascular disease. • as a low-dose regimen for the prevention of thromboembolic complications arising as a result of cardiac and arterial surgery. • as an anticoagulant during blood transfusions, extracorporeal circulation, dialysis and other perfusion techniques and in blood samples for laboratory purposes. 4.2 DOSE AND METHOD OF ADMINISTRATION Heparin Injection contains no antimicrobial agent and is therefore intended for single use only. Heparin may be given by intermittent intravenous injection, intravenous infusion or deep subcutaneous injection. It should not be given intramuscularly due to the risk of haematoma formation at the injection site. There is a wide variation between individuals in the dose required to control thromboembolism and heparin dose is usually determined empirically by adjustment according to the results of laboratory tests. Version: pfphepai10321 Supersedes: pfphepai10819 Page 2 of 14 THE DOSAGE OF HEPARIN SODIUM SHOULD BE ADJUSTED ACCORDING TO THE PATIENT'S COAGULATION TEST RESULTS. When hep Прочитать полный документ